findmyKOL
Clinical trialNCT05008783CompletedPhase 3Interventional

A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma

SponsorAkesoEnrollment610Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Peking University Cancer Hospital

    Beijing, Beijing Municipality, China

  • Fujian Provincial Cancer Hospital

    Fuzhou, Fujian, China

  • Fudan University Cancer Hospital

    Shanghai, Shanghai Municipality, China

  • Zhongshan Hospital, Fudan University

    Shanghai, Shanghai Municipality, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

  • Yunnan Cancer Hospital

    Kunming, Yunnan, China

  • the First Affiliated Hospital of Zhejiang University Medical College

    Hangzhou, Zhejiang, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Sept 2021
Primary completion
6 Dec 2024
Completion
1 Aug 2025
Last update posted
19 Nov 2025
Registered enrollment
610
Registry id
NCT05008783

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.